EODData

FRA, 1K9: Caredx Inc

20 Aug 2026
LAST:

39.40

CHANGE:
 0.20
OPEN:
39.40
HIGH:
39.40
ASK:
0.00
VOLUME:
0
CHG(%):
0.51
PREV:
39.20
LOW:
39.40
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
20 Aug 2639.4039.4039.4039.400
19 Aug 2639.2039.2039.2039.200
18 Aug 2639.2039.2039.2039.200
17 Aug 2638.6038.6038.6038.600
14 Aug 2640.6040.6040.6040.600
13 Aug 2640.6040.6040.6040.600
12 Aug 2640.6040.6040.6040.600
07 Aug 2638.4038.4038.4038.400
06 Aug 2639.0039.0039.0039.000
05 Aug 2640.6040.6040.6040.600

PROFILE

Name:Caredx Inc
About:CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI, a transplant quality tracking software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
Sector:Healthcare
Address:8000 Marina Boulevard, South San Francisco, CA, United States, 94005
Website:https://caredx.com
ISIN:US14167L1035
LEI:549300NQOFKL9NON0U06

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:14.56 
Forward P/E:64.10 
PEG Ratio:-0.12 
Price to Sales:3.13 
Price to Book:4.67 
Profit Margin:-0.02 
Operating Margin:0.02 
Return on Assets:-0.02 
Return on Equity:-0.02 
Revenue:361.64M 
EBITDA:1.06M 
Shares:53.23M 
Market Cap:2.097B 

TECHNICAL INDICATORS

MA5:39.400.0%
MA10:39.620.6%
MA20:36.787.1%
MA50:28.7737.0%
MA100:22.8572.4%
MA200:19.17105.5%
STO9:45.45
STO14:83.02 
RSI14:73.12 
WPR14:-16.98 
MTM14:8.80
ROC14:0.29 
ATR:1.33 
Week High:40.603.0%
Week Low:38.602.1%
Month High:41.204.6%
Month Low:30.60105.5%
Year High:41.204.6%
Year Low:9.83300.9%